PL370162A1 - Rozpadająca się w jamie ustnej (orodyspergowalna)kompozycja farmaceutyczna zawierająca perindopril - Google Patents

Rozpadająca się w jamie ustnej (orodyspergowalna)kompozycja farmaceutyczna zawierająca perindopril

Info

Publication number
PL370162A1
PL370162A1 PL03370162A PL37016203A PL370162A1 PL 370162 A1 PL370162 A1 PL 370162A1 PL 03370162 A PL03370162 A PL 03370162A PL 37016203 A PL37016203 A PL 37016203A PL 370162 A1 PL370162 A1 PL 370162A1
Authority
PL
Poland
Prior art keywords
perindopril
pharmaceutical composition
orodispersible pharmaceutical
orodispersible
composition
Prior art date
Application number
PL03370162A
Other languages
English (en)
Other versions
PL205473B1 (pl
Inventor
Patrick Wuthrich
Herve Rolland
Marc Julien
Original Assignee
Les Laboratoires Servier
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Les Laboratoires Servier filed Critical Les Laboratoires Servier
Publication of PL370162A1 publication Critical patent/PL370162A1/pl
Publication of PL205473B1 publication Critical patent/PL205473B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/556—Angiotensin converting enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Vascular Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL370162A 2002-01-23 2003-01-22 Rozpadająca się w jamie ustnej (orodyspergowalna) kompozycja farmaceutyczna zawierająca perindopril PL205473B1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0200790A FR2834893B1 (fr) 2002-01-23 2002-01-23 Composition pharmaceutique orodispersible de perindopril

Publications (2)

Publication Number Publication Date
PL370162A1 true PL370162A1 (pl) 2005-05-16
PL205473B1 PL205473B1 (pl) 2010-04-30

Family

ID=27589554

Family Applications (1)

Application Number Title Priority Date Filing Date
PL370162A PL205473B1 (pl) 2002-01-23 2003-01-22 Rozpadająca się w jamie ustnej (orodyspergowalna) kompozycja farmaceutyczna zawierająca perindopril

Country Status (26)

Country Link
US (3) US20050106237A1 (pl)
EP (1) EP1467750B1 (pl)
JP (1) JP4090997B2 (pl)
KR (1) KR100588224B1 (pl)
CN (1) CN1658898B (pl)
AR (1) AR038305A1 (pl)
AT (1) ATE332690T1 (pl)
AU (1) AU2003215708B2 (pl)
BR (1) BRPI0307048B1 (pl)
CA (1) CA2473205C (pl)
CY (1) CY1105655T1 (pl)
DE (1) DE60306747T2 (pl)
DK (1) DK1467750T3 (pl)
EA (1) EA007181B1 (pl)
ES (1) ES2268372T3 (pl)
FR (1) FR2834893B1 (pl)
GE (1) GEP20063821B (pl)
MA (1) MA27099A1 (pl)
MX (1) MXPA04007195A (pl)
NO (1) NO333723B1 (pl)
NZ (1) NZ533821A (pl)
PL (1) PL205473B1 (pl)
PT (1) PT1467750E (pl)
UA (1) UA78279C2 (pl)
WO (1) WO2003061691A1 (pl)
ZA (1) ZA200405009B (pl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005067887A2 (en) * 2004-03-24 2005-07-28 Actavis Group Formulations of ramipril
DE102004019845A1 (de) * 2004-03-29 2005-10-20 Krka Tovarna Zdravil D D Verfahren zur Herstellung einer festen pharmazeutischen Zusammensetzung
SK50252005A3 (sk) * 2005-03-22 2006-10-05 Vúlm, A.S. Farmaceutický prípravok obsahujúci perindopril erbumín, spôsob jeho prípravy a stabilizácie
GB0518129D0 (en) * 2005-09-06 2005-10-12 Arrow Int Ltd Ramipril formulation
US20070098782A1 (en) * 2005-10-28 2007-05-03 Selamine Limited Ramipril Formulation
GB2431579A (en) * 2005-10-28 2007-05-02 Arrow Int Ltd Ramipril formulations
GB0624087D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril combination salt
GB0624090D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril amine salts
GB0624084D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril amino acid salts
LT2886108T (lt) * 2013-12-23 2019-03-25 Dr. Falk Pharma Gmbh Optimizuota farmacinė kompozicija, skirta stemplės uždegiminių pakitimų gydymui
US20170042806A1 (en) * 2015-04-29 2017-02-16 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3506276C1 (de) * 1985-02-22 1986-04-24 Meggle Milchindustrie Gmbh & Co Kg, 8094 Reitmehring Direkttablettiermittel
TW391880B (en) * 1994-01-31 2000-06-01 Yamanouchi Pharma Co Ltd An oral soluble type compression moulding and its preparation
EP1058538B9 (en) * 1998-03-06 2013-01-02 Aptalis Pharma S.r.l. Fast disintegrating tablets
CA2374760A1 (en) * 1999-06-18 2000-12-28 Takeda Chemical Industries, Ltd. Quickly disintegrating solid preparations
FR2811318B1 (fr) * 2000-07-06 2002-08-23 Adir Nouvelle forme cristalline gamma du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent
EP1175899B1 (fr) * 2000-07-27 2007-08-29 Roquette FrÀ¨res Granules à base d'amidon et de lactose
US6651768B2 (en) * 2000-11-06 2003-11-25 Bombardier Inc. Snowmobile engine mount
FR2834889B1 (fr) * 2002-01-18 2004-04-02 Roquette Freres Forme pharmaceutique solide orodispersible

Also Published As

Publication number Publication date
PL205473B1 (pl) 2010-04-30
MXPA04007195A (es) 2004-10-29
US20050106237A1 (en) 2005-05-19
NZ533821A (en) 2005-08-26
WO2003061691A1 (fr) 2003-07-31
HK1076743A1 (en) 2006-01-27
JP4090997B2 (ja) 2008-05-28
US20100267799A1 (en) 2010-10-21
FR2834893A1 (fr) 2003-07-25
ATE332690T1 (de) 2006-08-15
PT1467750E (pt) 2006-11-30
FR2834893B1 (fr) 2004-02-27
EP1467750A1 (fr) 2004-10-20
BRPI0307048B1 (pt) 2015-06-30
DE60306747D1 (de) 2006-08-24
NO333723B1 (no) 2013-09-02
CA2473205A1 (fr) 2003-07-31
ES2268372T3 (es) 2007-03-16
MA27099A1 (fr) 2004-12-20
EP1467750B1 (fr) 2006-07-12
AU2003215708B2 (en) 2007-07-19
KR100588224B1 (ko) 2006-06-12
NO20043473L (no) 2004-08-20
CY1105655T1 (el) 2010-12-22
GEP20063821B (en) 2006-05-10
CN1658898A (zh) 2005-08-24
DE60306747T2 (de) 2007-08-02
CA2473205C (fr) 2010-05-18
EA200400884A1 (ru) 2004-12-30
KR20040078130A (ko) 2004-09-08
JP2005523256A (ja) 2005-08-04
AU2003215708B8 (en) 2003-09-02
UA78279C2 (en) 2007-03-15
DK1467750T3 (da) 2006-11-13
ZA200405009B (en) 2005-08-31
EA007181B1 (ru) 2006-08-25
CN1658898B (zh) 2012-10-03
US20120076856A1 (en) 2012-03-29
AU2003215708B9 (en) 2003-09-02
BR0307048A (pt) 2004-10-26
AR038305A1 (es) 2005-01-12

Similar Documents

Publication Publication Date Title
GB2389530B (en) Pharmaceutical compositions
AU2003291103A8 (en) Pharmaceutical composition
SI1467724T1 (sl) Orodisperzibilen farmacevtski sestavek z agomelatinom
AU2003220786A1 (en) Orodispersible pharmaceutical composition comprising agomelatine
IL164547A0 (en) Pharmaceutical composition
AP2004003154A0 (en) Novel perindopril salt and pharmaceutical compositions containing same.
AU2003250372A8 (en) Pharmaceutical composition
GB2391473B (en) Pharmaceutical compositions
PL376015A1 (pl) Kompozycja farmaceutyczna zawierająca mikrocząstki z oktreotydem
AU2003215708A1 (en) Orodispersible pharmaceutical composition comprising perindopril
PL370161A1 (pl) Rozpadająca się w jamie ustnej (orodyspergowalna)kompozycja farmaceutyczna zawierająca iwabradynę
AU2003215706A1 (en) Orodispersible pharmaceutical composition comprising ivabradine
DK1467750T3 (da) Orodispergerbar farmaceutisk sammensætning omfattende perindopril
GB0213481D0 (en) Pharmaceutical compositions
IL173626A0 (en) Small peptides and oral pharmaceutical compositions containing the same
SI1467750T1 (sl) Farmacevtski sestavek perindoprila disperzen v ustih (orodisperzen)
PL370907A1 (pl) Kompozycje farmaceutyczne
GB0217703D0 (en) Pharmaceutical composition
AU2003219239A1 (en) Orodispersible pharmaceutical composition comprising mitiglinide
AU2003219238A1 (en) Orodispersible pharmaceutical composition comprising testosterone
GB0213267D0 (en) Pharmaceutical composition
GB0228111D0 (en) Pharmaceutical composition
GB0213305D0 (en) Pharmaceutical composition
GB0225042D0 (en) Pharmaceutical composition
GB0220095D0 (en) Pharmaceutical composition